跳至主要内容
临床试验/JPRN-UMIN000020326
JPRN-UMIN000020326招募中未知

Various visual functions and vision-related quality of life in patients with macular edema secondary to retinal vein occlusion following intravitreal ranibizumab injection. - Various visual functions and vision-related quality of life in patients with macular edema secondary to retinal vein occlusion following intravitreal ranibizumab injection.

niversity of Tsukuba0 个研究点目标入组 46 人开始时间: 2016年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Previous history of vitreoretinal surgery 2) Previous history of ophthalmic disorders except mild refractive errors and mild cataract 3) Within 90 days of macular edema treatment [ including sub-Tenon triamcinolone acetonide (STTA), intravitreal bevacizumab (IVB), intravitreal ranibizumab (IVR), intravitreal aflibercept (IVA), topical steroid, carbonic anhydrase inhibitors (CAI) ] 4) Within 90 days of intraocular surgery 5) Contralateral eye of RVO 6) Poor control of hypertension (HT) and diabetic mellitus (DM) 7) Within 30 days of laser treatment

研究者

发起方
niversity of Tsukuba

相似试验